Cargando…

Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant

Background: Epstein–Barr virus (EBV) and cytomegalovirus (CMV) infections can have serious consequences during the period of aplasia and lymphopenia following hematopoietic stem cell transplantation (HSCT). Large pediatric cohort studies examining the effect of antiviral prophylaxis against these vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diop, Ndeye Soukeyna, Enok Bonong, Pascal Roland, Buteau, Chantal, Duval, Michel, Lacroix, Jacques, Laporte, Louise, Tucci, Marisa, Robitaille, Nancy, Spinella, Philip C., Cuvelier, Geoffrey, Vercauteren, Suzanne M, Lewis, Victor, Alfieri, Caroline, Trottier, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226807/ https://www.ncbi.nlm.nih.gov/pubmed/34200239 http://dx.doi.org/10.3390/vaccines9060610

Ejemplares similares

Factors Associated with Post-Transplant Active Epstein-Barr Virus Infection and Lymphoproliferative Disease in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis
por: Enok Bonong, Pascal Roland, et al.
Publicado: (2021)

934. Epidemiology and Outcomes of Epstein-Barr Virus DNAemia in Adult Solid Organ Transplant Recipients
por: Dong, Sara W, et al.
Publicado: (2021)

Genomic Markers Associated with Cytomegalovirus DNAemia in Kidney Transplant Recipients
por: Shapira, Guy, et al.
Publicado: (2023)

Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients
por: Baldanti, Fausto, et al.
Publicado: (2011)

Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients
por: Chang, Yeh-Chung, et al.
Publicado: (2022)

1750. Epidemiology of Cytomegalovirus DNAemia in Pediatric Solid-Organ Transplant Patients
por: Valencia Deray, Kristen, et al.
Publicado: (2019)

The risk of early and late cytomegalovirus DNAemia associated with Campath use in stem cell transplant recipients
por: Buyck, Hubertus C, et al.
Publicado: (2009)

Evaluation of risk factors for cytomegalovirus DNAemia after end of regular prophylaxis after heart transplantation
por: Immohr, Moritz Benjamin, et al.
Publicado: (2023)

2104. Cytomegalovirus DNAemia Patterns in Mismatched Solid Organ Transplant Recipients: A Retrospective Cohort Study.
por: Garcia, Oscar A Fernandez, et al.
Publicado: (2022)

Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation
por: Zhou, Jing-Rui, et al.
Publicado: (2021)

Cytomegalovirus and Epstein-Barr Virus in Breast Cancer
por: Richardson, Ann K., et al.
Publicado: (2015)

Unexpectedly High Prevalence of Cytomegalovirus DNAemia in Older Children and Adolescents With Perinatally Acquired Human Immunodeficiency Virus Infection
por: Yindom, Louis-Marie, et al.
Publicado: (2019)

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
por: Xuan, Li, et al.
Publicado: (2012)

Integrating Gestational Diabetes Screening and Care and Type 2 Diabetes Mellitus Prevention After GDM Into Community Based Primary Health Care in South Africa-Mixed Method Study
por: Mutabazi, Jean Claude, et al.
Publicado: (2022)

Synchronous tuberculosis, Epstein-Barr virus-associated lymphoproliferative disorder and cytomegalovirus infection in an allogeneic transplant recipient: a case report
por: Ostendorf, Benjamin Nils, et al.
Publicado: (2014)

Integrating gestational diabetes and type 2 diabetes care into primary health care: Lessons from prevention of mother-to-child transmission of HIV in South Africa - A mixed methods study
por: Mutabazi, Jean Claude, et al.
Publicado: (2021)

1588. Epidemiology of Chronic High Level (CHL) Epstein-Barr virus (EBV) DNAemia in Pediatric Solid Organ Transplant Recipients (SOTR) at Texas Children’s Hospital (TCH)
por: Valencia Deray, Kristen G, et al.
Publicado: (2022)

Plasma proteome perturbation for CMV DNAemia in kidney transplantation
por: Sigdel, Tara K., et al.
Publicado: (2023)

Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug Resistance
por: Acquier, M, et al.
Publicado: (2023)

Detection of Human Cytomegalovirus and Epstein-Barr Virus in Coronary Atherosclerotic Tissue
por: Imbronito, Ana Vitória, et al.
Publicado: (2010)

Quantification of Epstein-Barr Virus and Human Cytomegalovirus in Chronic Periodontal Patients
por: Khosropanah, Hengameh, et al.
Publicado: (2015)

Cytomegalovirus and Epstein-Barr Infections: Prevalence and Impact on Patients with Hematological Diseases
por: de Melo Silva, Jean, et al.
Publicado: (2020)

REACTIVATION OF EPSTEIN-BARR VIRUS AND CYTOMEGALOVIRUS INFECTION IN PATIENTS WITH COVID-19
por: ALMAGUER, ANGELICA, et al.
Publicado: (2022)

Epstein–Barr virus and cytomegalovirus coinfection in Egyptian COVID-19 patients
por: Barakat, Eman F, et al.
Publicado: (2023)

Splenic Infarction in Acute Cytomegalovirus and Epstein-Barr Virus Concomitant Infection
por: Kana, Tina, et al.
Publicado: (2023)

Aged-associated cytomegalovirus and Epstein-Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women
por: Thomasini, Ronaldo Luis, et al.
Publicado: (2017)

Bacterial DNAemia is associated with serum zonulin levels in older subjects
por: Gargari, Giorgio, et al.
Publicado: (2021)

Demonstration of Herpes Simplex Virus, Cytomegalovirus, and Epstein-Barr Virus in Colorectal Cancer
por: Mehrabani-Khasraghi, Sahar, et al.
Publicado: (2016)

Epstein-Barr Virus and Cytomegalovirus induced Acute Hepatitis in Young Female Patient
por: Ates, İhsan, et al.
Publicado: (2015)

Epstein–Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer
por: Liu, Zhenjiang, et al.
Publicado: (2018)

Cytomegalovirus and Epstein–Barr Virus Associations with Neurological Diseases and the Need for Vaccine Development
por: Maple, Peter A. C.
Publicado: (2020)

A Clinicopathological Study of Cytomegalovirus Lymphadenitis and Tonsillitis and Their Association with Epstein–Barr Virus
por: Yu, Shan-Chi, et al.
Publicado: (2021)

Adalimumab/mercaptopurine/mesalazine: Epstein-Barr virus and cytomegalovirus infections: case report
Publicado: (2022)

P1561: HBSAG-POSITIVE PATIENTS WITH CO-REACTIVATION OF CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUSES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATED WITH POOR SURVIVAL
por: Ren, Jinhua, et al.
Publicado: (2023)

Human Herpesvirus 8 in Australia: DNAemia and Cumulative Exposure in Blood Donors
por: Speicher, David J., et al.
Publicado: (2022)

Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation
por: Wu, Xiu-li, et al.
Publicado: (2012)

Breast cancer, cytomegalovirus and Epstein–Barr virus: a nested case–control study
por: Cox, B, et al.
Publicado: (2010)

Epstein-Barr Virus but Not Cytomegalovirus Is Associated with Reduced Vaccine Antibody Responses in Gambian Infants
por: Holder, Beth, et al.
Publicado: (2010)

Epstein-Barr virus and cytomegalovirus infections and their clinical relevance in Egyptian leukemic pediatric patients
por: Loutfy, Samah Aly, et al.
Publicado: (2017)

Elevated Antibody Titers to Epstein–Barr Virus and Cytomegalovirus in Patients with Drug-Induced Lupus
por: Knudsen, Julie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9iil1rpllnkpt5j2qadjlh92n5